Insulin resistance is one of the most under-diagnosed conditions affecting women in their 30s, 40s, and beyond. It’s at the root of unexplained weight gain, persistent fatigue, brain fog, and sugar cravings — yet it rarely shows up on standard lab panels until it has been silently progressing for years.
If you’ve been told your blood sugar is “normal” but still feel like something is off, insulin resistance may be the missing piece.
What Is Insulin Resistance?
Insulin is a hormone made by your pancreas. Its job is to act like a key — unlocking your cells so glucose can enter and be used for energy. When you’re insulin resistant, the locks on your cells become stiff. The key still fits, but it doesn’t work as well. Your pancreas responds by making more and more insulin just to get the same result.
Over time, those elevated insulin levels drive fat storage, inflammation, hormonal disruption, and eventually, type 2 diabetes — unless the pattern is interrupted.
Why Women Over 35 Are Especially Vulnerable
Several factors collide in your mid-30s to accelerate insulin resistance. Declining estrogen reduces insulin sensitivity. Chronic stress raises cortisol, which raises blood sugar, which raises insulin. Muscle mass decreases, and since muscle is the primary site where glucose is absorbed, less muscle means less glucose clearance.
Many women with insulin resistance also have polycystic ovarian syndrome (PCOS), thyroid dysfunction, or are in perimenopause — all of which compound insulin signaling problems.
The Signs You Might Be Missing
Insulin resistance rarely announces itself obviously. Instead, it shows up as energy crashes after meals, difficulty losing weight despite eating well, intense carbohydrate cravings, skin changes like dark patches around the neck (acanthosis nigricans), and difficulty concentrating. Many women spend years addressing these symptoms individually without ever identifying the common thread.
How We Approach It Differently
At Nuu Metabolic in Illinois, we run fasting insulin alongside glucose and HbA1c to calculate HOMA-IR — a reliable marker of insulin resistance that standard labs often skip. We also evaluate inflammatory markers, hormone panels, and nutrient levels that interact with insulin signaling.
Treatment is personalized, not one-size-fits-all. For some women, targeted nutrition and exercise adjustments make a significant difference. For others, medications like metformin or GLP-1 receptor agonists may be appropriate bridges while the metabolic environment is repaired from the inside out.
Recognizing insulin resistance early is one of the most powerful things you can do for your long-term health. The sooner it’s addressed, the more options you have.
— Urooj Mujtaba, PA-C | Nuu Metabolic, Illinois